To test this hypothesis at a functional level, we performed orthotopic transplantation experiments using fresh tumor-derived organoids from EPC mice in which we deleted either a candidate TF using single guide RNAs (sgRNAs), or a nontargeting sgRNA as a control, using weight of the injected lobe as a quick readout of disease burden (Fig. 6g). This evidence concerns the gene TF and neoplasm.